Overview
Dina Naguib practices in Caen, France. Ms. Naguib is rated as an Advanced expert by MediFind in the treatment of Splenomegaly. Her top areas of expertise are Splenomegaly, Hairy Cell Leukemia (HCL), Lymphomatoid Papulosis, Hypereosinophilic Syndrome, and Splenectomy.
Her clinical research consists of co-authoring 12 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Splenomegaly.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hairy Cell Leukemia (HCL)Ms. Naguib isAdvanced. Learn about Hairy Cell Leukemia (HCL).
- Lymphomatoid PapulosisMs. Naguib isAdvanced. Learn about Lymphomatoid Papulosis.
- SplenomegalyMs. Naguib isAdvanced. Learn about Splenomegaly.
- Experienced
- Chronic B-Cell Leukemia (CBCL)Ms. Naguib isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Naguib isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Chronic Myelogenous Leukemia (CML)Ms. Naguib isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Cutaneous T-Cell Lymphoma (CTCL)Ms. Naguib isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Hypereosinophilic SyndromeMs. Naguib isExperienced. Learn about Hypereosinophilic Syndrome.
- LeukemiaMs. Naguib isExperienced. Learn about Leukemia.